🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchCan we talk about how SLOW the FDA is Page 7

Can we talk about how SLOW the FDA is

KarenAZ_mom Fri, Jan 23, 2026 at 10:27 AM 38 replies 1,036 viewsPage 7 of 8
julia.endo
Senior Member
1,890
9,012
Feb 2024
Cincinnati, OH
Jan 23, 2026 at 8:22 PM#31

Congrats KarenAZ_mom!! You should be so proud of yourself. 🎉 👏

Last edited: Jan 24, 2026 at 2:22 AM
42 17anna.melb_AU, mark_tokyo, hans_munich and 39 others
Reply Quote Save Share Report
jennifer_SEA
Member
234
890
Nov 2024
Seattle, WA
Jan 23, 2026 at 8:39 PM#32

Agreed. My doctor said the same thing about Can we talk about.

25 23Dr.ReproEndo, lucas_SP_BR, lisa_labSD and 22 others
Reply Quote Save Share Report
KarenAZ_mom
Member
567
2,567
Aug 2024
Scottsdale, AZ
Jan 23, 2026 at 8:56 PM#33

OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on Can we talk about how.

To answer KarenAZ_mom: yes, I am on compounded sema from a 503B pharmacy.

Quick update: things are still going well. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏

Last edited: Jan 24, 2026 at 1:56 AM
21 21bri_stats, pete_manc_UK, anna.melb_AU and 18 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
fiona_glasgow
Member
312
1,345
Aug 2024
Glasgow, UK
Jan 23, 2026 at 9:13 PM#34

This thread is incredible for Can we talk about info. Better than most online groups.

50 11JessicaH_TX, KevinCompounds, TirzTom and 47 others
Reply Quote Save Share Report
carlos_SATX
Member
245
1,123
Oct 2024
San Antonio, TX
Jan 23, 2026 at 9:30 PM#35

Congrats KarenAZ_mom!! You should be so proud of yourself. 🎉

8 20tommy_boulder, hyun_seoul, jim_asheville and 5 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register